| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hong Kong | 53 | 2021 | 3361 | 3.11 | Why? |
| Coronaviridae | 10 | 2014 | 923 | 2.75 | Why? |
| Severe Acute Respiratory Syndrome | 64 | 2021 | 12361 | 2.67 | Why? |
| SARS Virus | 76 | 2020 | 13021 | 2.54 | Why? |
| Chiroptera | 27 | 2021 | 3530 | 2.40 | Why? |
| Coronavirus | 54 | 2021 | 18339 | 2.35 | Why? |
| Camelus | 11 | 2020 | 1425 | 2.24 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 27 | 2020 | 8843 | 2.21 | Why? |
| Membrane Glycoproteins | 23 | 2018 | 2273 | 2.12 | Why? |
| Animals | 154 | 2021 | 78931 | 2.05 | Why? |
| Genome, Viral | 45 | 2021 | 13157 | 1.97 | Why? |
| Phylogeny | 61 | 2021 | 13341 | 1.91 | Why? |
| Apoptosis | 8 | 2021 | 2335 | 1.85 | Why? |
| Viral Envelope Proteins | 26 | 2020 | 3539 | 1.77 | Why? |
| Molecular Diagnostic Techniques | 13 | 2020 | 4239 | 1.77 | Why? |
| Virus Replication | 39 | 2021 | 14331 | 1.68 | Why? |
| Sequence Analysis, DNA | 31 | 2019 | 2830 | 1.67 | Why? |
| Molecular Sequence Data | 33 | 2018 | 3198 | 1.63 | Why? |
| Antiviral Agents | 43 | 2021 | 41703 | 1.59 | Why? |
| Viral Load | 37 | 2021 | 15850 | 1.57 | Why? |
| Virus Attachment | 5 | 2021 | 1259 | 1.55 | Why? |
| Respiratory Tract Infections | 16 | 2019 | 6817 | 1.52 | Why? |
| Coronavirus Infections | 94 | 2021 | 253789 | 1.50 | Why? |
| Zika Virus | 9 | 2020 | 1924 | 1.48 | Why? |
| Picobirnavirus | 2 | 2019 | 15 | 1.40 | Why? |
| Disease Reservoirs | 10 | 2020 | 1672 | 1.40 | Why? |
| Cricetinae | 17 | 2021 | 3344 | 1.39 | Why? |
| Cell Line | 39 | 2021 | 12040 | 1.36 | Why? |
| Peptides | 10 | 2021 | 2513 | 1.34 | Why? |
| Paramyxoviridae | 2 | 2017 | 67 | 1.32 | Why? |
| Paramyxoviridae Infections | 3 | 2017 | 364 | 1.32 | Why? |
| Influenza A virus | 9 | 2020 | 2234 | 1.31 | Why? |
| Fungal Proteins | 3 | 2018 | 133 | 1.29 | Why? |
| Coronaviridae Infections | 4 | 2018 | 442 | 1.28 | Why? |
| Astroviridae | 2 | 2017 | 57 | 1.26 | Why? |
| Air Microbiology | 3 | 2021 | 1322 | 1.24 | Why? |
| Astroviridae Infections | 2 | 2017 | 56 | 1.23 | Why? |
| Intestinal Mucosa | 5 | 2021 | 1046 | 1.22 | Why? |
| 5' Untranslated Regions | 4 | 2017 | 375 | 1.22 | Why? |
| Viral Proteins | 23 | 2021 | 7370 | 1.22 | Why? |
| Influenza, Human | 19 | 2021 | 10779 | 1.21 | Why? |
| Enterovirus Infections | 4 | 2021 | 404 | 1.21 | Why? |
| Saliva | 10 | 2020 | 4679 | 1.20 | Why? |
| Recombination, Genetic | 10 | 2018 | 1265 | 1.20 | Why? |
| Rodent Diseases | 2 | 2017 | 115 | 1.16 | Why? |
| Virulence Factors | 3 | 2018 | 338 | 1.15 | Why? |
| Genes, Viral | 8 | 2018 | 1428 | 1.15 | Why? |
| Mesocricetus | 13 | 2021 | 1847 | 1.15 | Why? |
| Rhinovirus | 4 | 2020 | 979 | 1.11 | Why? |
| Nucleocapsid Proteins | 19 | 2020 | 3120 | 1.11 | Why? |
| Genotype | 12 | 2019 | 4697 | 1.10 | Why? |
| Hepatitis E virus | 2 | 2018 | 306 | 1.10 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 33 | 2020 | 13720 | 1.09 | Why? |
| Influenza A Virus, H1N1 Subtype | 6 | 2021 | 2984 | 1.08 | Why? |
| Zika Virus Infection | 7 | 2020 | 1920 | 1.07 | Why? |
| Real-Time Polymerase Chain Reaction | 14 | 2020 | 11367 | 1.07 | Why? |
| Lipid Metabolism | 2 | 2019 | 572 | 1.07 | Why? |
| Intestines | 5 | 2021 | 817 | 1.05 | Why? |
| Hepatitis E | 2 | 2018 | 319 | 1.04 | Why? |
| Bocavirus | 2 | 2017 | 74 | 1.04 | Why? |
| Vero Cells | 25 | 2021 | 14117 | 1.02 | Why? |
| Virus Internalization | 9 | 2021 | 7921 | 1.01 | Why? |
| Mice | 40 | 2021 | 21357 | 1.01 | Why? |
| Humans | 284 | 2021 | 930598 | 1.00 | Why? |
| Coronavirus 229E, Human | 8 | 2021 | 1241 | 1.00 | Why? |
| Betacoronavirus | 50 | 2020 | 204454 | 1.00 | Why? |
| Pneumonia, Viral | 57 | 2020 | 243684 | 1.00 | Why? |
| Influenza A Virus, H7N9 Subtype | 6 | 2019 | 415 | 0.99 | Why? |
| Disease Outbreaks | 32 | 2021 | 27595 | 0.99 | Why? |
| Cestoda | 2 | 2019 | 9 | 0.99 | Why? |
| Genetic Variation | 8 | 2021 | 3919 | 0.98 | Why? |
| Disease Models, Animal | 25 | 2021 | 10998 | 0.97 | Why? |
| Cross Infection | 15 | 2021 | 8675 | 0.97 | Why? |
| Mice, Inbred BALB C | 23 | 2021 | 5814 | 0.96 | Why? |
| Immunity, Innate | 9 | 2020 | 6570 | 0.96 | Why? |
| Interferon-beta | 3 | 2020 | 979 | 0.96 | Why? |
| Nematoda | 2 | 2019 | 34 | 0.95 | Why? |
| Antibodies, Viral | 54 | 2021 | 51949 | 0.95 | Why? |
| RNA Virus Infections | 2 | 2019 | 231 | 0.94 | Why? |
| Nasopharynx | 23 | 2020 | 10224 | 0.94 | Why? |
| Dendritic Cells | 4 | 2020 | 1330 | 0.93 | Why? |
| Macrophages | 8 | 2021 | 2784 | 0.92 | Why? |
| Bird Diseases | 3 | 2018 | 130 | 0.91 | Why? |
| Evolution, Molecular | 15 | 2021 | 3691 | 0.90 | Why? |
| Ribavirin | 6 | 2020 | 1182 | 0.90 | Why? |
| Parvoviridae Infections | 2 | 2017 | 222 | 0.88 | Why? |
| Open Reading Frames | 13 | 2020 | 1898 | 0.88 | Why? |
| Adaptor Proteins, Vesicular Transport | 2 | 2020 | 88 | 0.88 | Why? |
| Interferon Inducers | 1 | 2020 | 27 | 0.87 | Why? |
| Acinetobacter Infections | 3 | 2021 | 273 | 0.87 | Why? |
| Air Ionization | 1 | 2020 | 5 | 0.87 | Why? |
| Clofazimine | 1 | 2021 | 85 | 0.86 | Why? |
| Antigens, Fungal | 3 | 2018 | 106 | 0.86 | Why? |
| Olfactory Receptor Neurons | 1 | 2021 | 110 | 0.86 | Why? |
| Interferon beta-1b | 2 | 2020 | 274 | 0.86 | Why? |
| Spike Glycoprotein, Coronavirus | 48 | 2021 | 37182 | 0.86 | Why? |
| eIF-2 Kinase | 1 | 2021 | 117 | 0.85 | Why? |
| Acinetobacter baumannii | 3 | 2021 | 378 | 0.85 | Why? |
| Vasopressins | 1 | 2021 | 70 | 0.85 | Why? |
| ortho-Aminobenzoates | 1 | 2020 | 46 | 0.84 | Why? |
| Lactams, Macrocyclic | 1 | 2020 | 130 | 0.84 | Why? |
| Orthomyxoviridae Infections | 7 | 2020 | 1001 | 0.84 | Why? |
| Cinnamates | 1 | 2020 | 50 | 0.83 | Why? |
| HSP90 Heat-Shock Proteins | 1 | 2020 | 98 | 0.83 | Why? |
| Hepacivirus | 3 | 2019 | 1509 | 0.82 | Why? |
| DNA, Bacterial | 3 | 2016 | 835 | 0.82 | Why? |
| Nematode Infections | 1 | 2019 | 5 | 0.81 | Why? |
| Enterovirus A, Human | 2 | 2021 | 180 | 0.81 | Why? |
| Trematoda | 1 | 2019 | 8 | 0.81 | Why? |
| Virus Shedding | 7 | 2020 | 5834 | 0.80 | Why? |
| Cestode Infections | 1 | 2019 | 10 | 0.80 | Why? |
| Benzoquinones | 1 | 2020 | 92 | 0.80 | Why? |
| Adenoviruses, Human | 2 | 2018 | 195 | 0.80 | Why? |
| Hedgehogs | 1 | 2019 | 56 | 0.80 | Why? |
| RNA, Viral | 36 | 2021 | 32276 | 0.80 | Why? |
| Dipeptidyl Peptidase 4 | 9 | 2021 | 1061 | 0.80 | Why? |
| Trematode Infections | 1 | 2019 | 9 | 0.80 | Why? |
| Sterol Regulatory Element Binding Proteins | 1 | 2019 | 22 | 0.78 | Why? |
| Tryptophan-tRNA Ligase | 1 | 2018 | 7 | 0.78 | Why? |
| Varicella Zoster Virus Infection | 1 | 2019 | 40 | 0.78 | Why? |
| Feces | 11 | 2019 | 4235 | 0.77 | Why? |
| Base Sequence | 19 | 2021 | 3581 | 0.77 | Why? |
| Equipment Contamination | 2 | 2018 | 1308 | 0.77 | Why? |
| Sialic Acids | 1 | 2021 | 218 | 0.77 | Why? |
| Tetrahydronaphthalenes | 1 | 2019 | 32 | 0.76 | Why? |
| Flufenamic Acid | 1 | 2018 | 6 | 0.76 | Why? |
| Liver Transplantation | 4 | 2019 | 2864 | 0.76 | Why? |
| Caliciviridae Infections | 2 | 2019 | 229 | 0.76 | Why? |
| Influenza A Virus, H7N7 Subtype | 1 | 2018 | 19 | 0.76 | Why? |
| Granulomatous Mastitis | 1 | 2018 | 8 | 0.75 | Why? |
| DEAD Box Protein 58 | 3 | 2020 | 250 | 0.75 | Why? |
| Antigens, Viral | 11 | 2021 | 6298 | 0.74 | Why? |
| Interferons | 8 | 2020 | 2885 | 0.74 | Why? |
| Benzodiazepinones | 1 | 2017 | 4 | 0.73 | Why? |
| Cross Reactions | 8 | 2018 | 4374 | 0.73 | Why? |
| Viral Tropism | 5 | 2020 | 1329 | 0.73 | Why? |
| Zanamivir | 1 | 2018 | 63 | 0.73 | Why? |
| Klebsiella oxytoca | 1 | 2017 | 8 | 0.73 | Why? |
| Corynebacterium Infections | 1 | 2018 | 26 | 0.72 | Why? |
| Enzyme-Linked Immunosorbent Assay | 18 | 2020 | 7868 | 0.72 | Why? |
| Norovirus | 2 | 2019 | 294 | 0.72 | Why? |
| STAT1 Transcription Factor | 1 | 2020 | 313 | 0.72 | Why? |
| Scarlet Fever | 1 | 2018 | 35 | 0.72 | Why? |
| Corynebacterium | 1 | 2018 | 47 | 0.72 | Why? |
| Rheumatic Heart Disease | 1 | 2018 | 44 | 0.71 | Why? |
| Benzoates | 1 | 2019 | 102 | 0.71 | Why? |
| Haemophilus | 1 | 2017 | 13 | 0.71 | Why? |
| Cytotoxins | 1 | 2017 | 57 | 0.71 | Why? |
| Genes, Bacterial | 2 | 2016 | 207 | 0.71 | Why? |
| Bacillaceae Infections | 1 | 2017 | 4 | 0.71 | Why? |
| Hepatitis, Chronic | 1 | 2017 | 53 | 0.70 | Why? |
| DNA, Ribosomal | 4 | 2019 | 112 | 0.70 | Why? |
| Enterovirus B, Human | 1 | 2018 | 124 | 0.70 | Why? |
| Encephalitis Virus, Japanese | 1 | 2018 | 63 | 0.69 | Why? |
| Bacillus | 1 | 2017 | 32 | 0.69 | Why? |
| Organoids | 3 | 2021 | 840 | 0.69 | Why? |
| Talaromyces | 1 | 2017 | 17 | 0.68 | Why? |
| Monkey Diseases | 1 | 2019 | 190 | 0.68 | Why? |
| Zoonoses | 6 | 2015 | 3034 | 0.68 | Why? |
| Clarithromycin | 1 | 2018 | 112 | 0.68 | Why? |
| Bromocriptine | 1 | 2017 | 42 | 0.68 | Why? |
| Adenoviridae Infections | 1 | 2018 | 150 | 0.68 | Why? |
| Encephalitis, Japanese | 1 | 2018 | 58 | 0.68 | Why? |
| Rabbits | 6 | 2017 | 1171 | 0.67 | Why? |
| Cytokines | 15 | 2021 | 15010 | 0.67 | Why? |
| Streptococcus pyogenes | 1 | 2018 | 118 | 0.67 | Why? |
| Bedding and Linens | 1 | 2017 | 53 | 0.67 | Why? |
| Haemophilus Infections | 1 | 2017 | 69 | 0.66 | Why? |
| Hand Disinfection | 2 | 2018 | 1671 | 0.66 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2018 | 115 | 0.66 | Why? |
| Cluster Analysis | 10 | 2019 | 3001 | 0.66 | Why? |
| Clinical Laboratory Techniques | 10 | 2020 | 23402 | 0.65 | Why? |
| Rodentia | 3 | 2017 | 235 | 0.65 | Why? |
| Enterocolitis, Pseudomembranous | 1 | 2017 | 93 | 0.65 | Why? |
| Cell Wall | 2 | 2014 | 62 | 0.65 | Why? |
| Virus Diseases | 4 | 2019 | 3779 | 0.65 | Why? |
| Lectins, C-Type | 1 | 2020 | 405 | 0.65 | Why? |
| Caco-2 Cells | 5 | 2021 | 1236 | 0.65 | Why? |
| Molecular Epidemiology | 9 | 2016 | 1638 | 0.65 | Why? |
| Haemophilus influenzae | 1 | 2017 | 196 | 0.64 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 449 | 0.64 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.64 | Why? |
| Smad7 Protein | 1 | 2016 | 32 | 0.64 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.63 | Why? |
| Sensitivity and Specificity | 29 | 2020 | 22971 | 0.63 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.63 | Why? |
| Amino Acid Sequence | 22 | 2020 | 6049 | 0.63 | Why? |
| Protective Clothing | 1 | 2020 | 468 | 0.63 | Why? |
| Multiplex Polymerase Chain Reaction | 3 | 2019 | 1439 | 0.62 | Why? |
| Cattle Diseases | 1 | 2019 | 294 | 0.62 | Why? |
| Quasispecies | 1 | 2017 | 108 | 0.62 | Why? |
| Common Cold | 3 | 2021 | 645 | 0.62 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2016 | 77 | 0.62 | Why? |
| Transcription, Genetic | 5 | 2021 | 1326 | 0.61 | Why? |
| Communicable Diseases, Emerging | 7 | 2013 | 2523 | 0.61 | Why? |
| Roseolovirus Infections | 1 | 2017 | 131 | 0.61 | Why? |
| Chickenpox | 1 | 2019 | 194 | 0.61 | Why? |
| Lopinavir | 5 | 2020 | 4308 | 0.61 | Why? |
| Heat-Shock Proteins | 2 | 2018 | 226 | 0.60 | Why? |
| Culture Media | 1 | 2018 | 366 | 0.60 | Why? |
| Carcinoembryonic Antigen | 1 | 2016 | 140 | 0.60 | Why? |
| Receptors, Virus | 10 | 2021 | 5659 | 0.60 | Why? |
| Nontuberculous Mycobacteria | 1 | 2016 | 114 | 0.60 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.60 | Why? |
| Cell Line, Tumor | 9 | 2021 | 3608 | 0.59 | Why? |
| Picornaviridae Infections | 2 | 2018 | 544 | 0.59 | Why? |
| Sequence Homology | 5 | 2019 | 448 | 0.59 | Why? |
| Aspergillus fumigatus | 1 | 2018 | 239 | 0.59 | Why? |
| Oligonucleotide Probes | 1 | 2015 | 88 | 0.59 | Why? |
| Endocarditis | 2 | 2018 | 368 | 0.59 | Why? |
| Ritonavir | 4 | 2020 | 4212 | 0.59 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.58 | Why? |
| Female | 98 | 2021 | 380317 | 0.58 | Why? |
| Herpesvirus 6, Human | 1 | 2017 | 162 | 0.58 | Why? |
| Laryngeal Neoplasms | 1 | 2017 | 202 | 0.58 | Why? |
| Virus Latency | 1 | 2017 | 251 | 0.57 | Why? |
| Viruses | 3 | 2019 | 2238 | 0.57 | Why? |
| Viral Nonstructural Proteins | 9 | 2020 | 4810 | 0.57 | Why? |
| Infection Control | 14 | 2021 | 23131 | 0.57 | Why? |
| International Agencies | 3 | 2020 | 202 | 0.57 | Why? |
| Sequence Alignment | 11 | 2020 | 2109 | 0.57 | Why? |
| Immunocompetence | 2 | 2008 | 280 | 0.57 | Why? |
| Influenza B virus | 2 | 2018 | 815 | 0.57 | Why? |
| Hydrogen Peroxide | 1 | 2020 | 680 | 0.56 | Why? |
| Circovirus | 1 | 2014 | 53 | 0.56 | Why? |
| Toll-Like Receptor 7 | 1 | 2018 | 402 | 0.56 | Why? |
| Virulence | 3 | 2021 | 2172 | 0.56 | Why? |
| Oligonucleotides | 1 | 2015 | 137 | 0.55 | Why? |
| Bottle-Nosed Dolphin | 1 | 2013 | 15 | 0.55 | Why? |
| Conjunctiva | 1 | 2020 | 620 | 0.55 | Why? |
| Drug Evaluation, Preclinical | 4 | 2021 | 3347 | 0.55 | Why? |
| Chemokines | 5 | 2020 | 1095 | 0.54 | Why? |
| HEK293 Cells | 13 | 2021 | 8394 | 0.54 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.54 | Why? |
| Mycoses | 3 | 2018 | 589 | 0.54 | Why? |
| Cryptococcus neoformans | 1 | 2014 | 71 | 0.54 | Why? |
| Male | 90 | 2021 | 367725 | 0.54 | Why? |
| Cells, Cultured | 12 | 2020 | 5835 | 0.54 | Why? |
| Host-Pathogen Interactions | 10 | 2021 | 11041 | 0.53 | Why? |
| Respiratory System | 6 | 2021 | 3213 | 0.53 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 3633 | 0.53 | Why? |
| Rats | 3 | 2018 | 2764 | 0.53 | Why? |
| Recombinant Proteins | 11 | 2017 | 3786 | 0.52 | Why? |
| Fomites | 1 | 2020 | 709 | 0.52 | Why? |
| Antibodies, Neutralizing | 23 | 2021 | 25288 | 0.52 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.51 | Why? |
| Coronavirus OC43, Human | 5 | 2012 | 1157 | 0.51 | Why? |
| Spleen | 5 | 2018 | 877 | 0.51 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.51 | Why? |
| Lipids | 2 | 2019 | 1079 | 0.51 | Why? |
| Environmental Microbiology | 2 | 2019 | 575 | 0.51 | Why? |
| Housing | 1 | 2021 | 1146 | 0.51 | Why? |
| Serine Proteinase Inhibitors | 1 | 2017 | 341 | 0.49 | Why? |
| Asymptomatic Infections | 4 | 2021 | 7218 | 0.49 | Why? |
| Bacteria | 2 | 2016 | 1897 | 0.49 | Why? |
| Pandemics | 52 | 2021 | 389249 | 0.48 | Why? |
| A549 Cells | 6 | 2020 | 2066 | 0.47 | Why? |
| Respiratory Mucosa | 2 | 2020 | 1522 | 0.47 | Why? |
| Protein Kinase Inhibitors | 2 | 2020 | 1585 | 0.47 | Why? |
| Hand Sanitizers | 1 | 2018 | 397 | 0.46 | Why? |
| Species Specificity | 7 | 2021 | 1356 | 0.45 | Why? |
| Lung | 21 | 2021 | 31049 | 0.45 | Why? |
| Eosinophils | 1 | 2018 | 848 | 0.44 | Why? |
| Enterovirus | 1 | 2015 | 402 | 0.44 | Why? |
| Drug Discovery | 5 | 2021 | 3092 | 0.43 | Why? |
| Hand Hygiene | 2 | 2020 | 1493 | 0.43 | Why? |
| Kidney | 7 | 2018 | 3648 | 0.43 | Why? |
| Epithelial Cells | 7 | 2021 | 3508 | 0.43 | Why? |
| Orthomyxoviridae | 2 | 2017 | 1168 | 0.42 | Why? |
| Vaccines, DNA | 2 | 2009 | 871 | 0.42 | Why? |
| Virus Inactivation | 1 | 2020 | 1139 | 0.42 | Why? |
| Whole Genome Sequencing | 6 | 2021 | 3239 | 0.42 | Why? |
| Birds | 4 | 2018 | 412 | 0.42 | Why? |
| Hepatitis B | 1 | 2019 | 888 | 0.42 | Why? |
| China | 26 | 2020 | 50654 | 0.42 | Why? |
| Protein Binding | 14 | 2021 | 11430 | 0.41 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2021 | 1115 | 0.41 | Why? |
| Aged | 54 | 2021 | 215776 | 0.41 | Why? |
| Animals, Domestic | 1 | 2012 | 272 | 0.41 | Why? |
| Bacterial Infections | 3 | 2016 | 2229 | 0.41 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.40 | Why? |
| Masks | 4 | 2021 | 8528 | 0.40 | Why? |
| Callithrix | 3 | 2016 | 288 | 0.40 | Why? |
| Middle Aged | 56 | 2021 | 270681 | 0.40 | Why? |
| Drug Repositioning | 5 | 2021 | 5683 | 0.40 | Why? |
| Antibodies, Monoclonal | 10 | 2020 | 8041 | 0.40 | Why? |
| Influenza in Birds | 2 | 2013 | 528 | 0.40 | Why? |
| Nucleocapsid | 3 | 2004 | 734 | 0.40 | Why? |
| Dermatomycoses | 1 | 2010 | 55 | 0.39 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.39 | Why? |
| Physiological Phenomena | 1 | 2008 | 7 | 0.39 | Why? |
| CARD Signaling Adaptor Proteins | 2 | 2020 | 70 | 0.39 | Why? |
| Lymphocyte Activation | 2 | 2020 | 2742 | 0.39 | Why? |
| Patient Participation | 1 | 2017 | 829 | 0.39 | Why? |
| Mammals | 1 | 2012 | 315 | 0.39 | Why? |
| Adult | 59 | 2021 | 244371 | 0.39 | Why? |
| Middle East | 4 | 2015 | 1418 | 0.39 | Why? |
| Mucorales | 1 | 2010 | 92 | 0.38 | Why? |
| Protein Transport | 3 | 2020 | 487 | 0.38 | Why? |
| Immunocompromised Host | 5 | 2019 | 5150 | 0.37 | Why? |
| Point-of-Care Testing | 2 | 2021 | 2782 | 0.37 | Why? |
| Madin Darby Canine Kidney Cells | 3 | 2020 | 640 | 0.37 | Why? |
| Organ Culture Techniques | 2 | 2020 | 119 | 0.37 | Why? |
| Monocytes | 2 | 2020 | 2978 | 0.37 | Why? |
| RNA, Small Interfering | 3 | 2020 | 817 | 0.36 | Why? |
| In Vitro Techniques | 3 | 2020 | 1027 | 0.36 | Why? |
| Metagenomics | 1 | 2014 | 823 | 0.36 | Why? |
| Infectious Mononucleosis | 1 | 2008 | 35 | 0.36 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.36 | Why? |
| Gene Expression Regulation | 6 | 2020 | 4020 | 0.36 | Why? |
| Nose Diseases | 1 | 2010 | 139 | 0.35 | Why? |
| Injections, Intramuscular | 4 | 2017 | 800 | 0.35 | Why? |
| Viral Vaccines | 12 | 2020 | 7560 | 0.35 | Why? |
| Gene Knockdown Techniques | 2 | 2020 | 347 | 0.35 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.35 | Why? |
| Influenza A Virus, H5N1 Subtype | 4 | 2018 | 492 | 0.35 | Why? |
| Seasons | 5 | 2018 | 4071 | 0.35 | Why? |
| Arachidonic Acid | 2 | 2019 | 90 | 0.35 | Why? |
| Colony Count, Microbial | 2 | 2018 | 177 | 0.35 | Why? |
| Viral Matrix Proteins | 6 | 2016 | 1243 | 0.35 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.35 | Why? |
| Aerosols | 2 | 2021 | 5393 | 0.35 | Why? |
| Serologic Tests | 7 | 2020 | 4359 | 0.35 | Why? |
| Sequence Homology, Amino Acid | 5 | 2017 | 945 | 0.34 | Why? |
| RNA, Ribosomal, 16S | 3 | 2017 | 793 | 0.34 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.34 | Why? |
| Microbial Sensitivity Tests | 6 | 2021 | 2886 | 0.34 | Why? |
| Disinfection | 2 | 2020 | 2912 | 0.34 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.34 | Why? |
| Endosomes | 3 | 2020 | 490 | 0.33 | Why? |
| Crossing Over, Genetic | 1 | 2006 | 11 | 0.33 | Why? |
| Neutralization Tests | 12 | 2021 | 6698 | 0.33 | Why? |
| HLA-C Antigens | 1 | 2008 | 195 | 0.33 | Why? |
| United Arab Emirates | 4 | 2020 | 704 | 0.33 | Why? |
| Antibody Formation | 3 | 2018 | 4038 | 0.33 | Why? |
| Coinfection | 4 | 2021 | 6820 | 0.32 | Why? |
| Dogs | 4 | 2020 | 2529 | 0.32 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.31 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.31 | Why? |
| Cytopathogenic Effect, Viral | 2 | 2020 | 635 | 0.30 | Why? |
| Genes, pol | 4 | 2012 | 38 | 0.30 | Why? |
| Macaca mulatta | 6 | 2019 | 3716 | 0.30 | Why? |
| Capsid Proteins | 3 | 2018 | 365 | 0.30 | Why? |
| Aged, 80 and over | 24 | 2021 | 88759 | 0.30 | Why? |
| Haplorhini | 2 | 2019 | 307 | 0.29 | Why? |
| RNA Viruses | 2 | 2017 | 824 | 0.29 | Why? |
| Metapneumovirus | 1 | 2008 | 465 | 0.29 | Why? |
| Multigene Family | 1 | 2006 | 377 | 0.29 | Why? |
| Community-Acquired Infections | 2 | 2009 | 2328 | 0.29 | Why? |
| Transplant Recipients | 2 | 2018 | 4982 | 0.29 | Why? |
| Specimen Handling | 4 | 2020 | 6190 | 0.29 | Why? |
| Protease Inhibitors | 2 | 2021 | 3630 | 0.29 | Why? |
| Contact Tracing | 3 | 2021 | 8448 | 0.28 | Why? |
| Reproducibility of Results | 9 | 2020 | 11304 | 0.28 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.28 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| Immunization | 5 | 2018 | 2019 | 0.28 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.28 | Why? |
| DNA, Viral | 5 | 2017 | 2521 | 0.27 | Why? |
| Injections, Intraperitoneal | 2 | 2018 | 69 | 0.27 | Why? |
| Fatal Outcome | 5 | 2019 | 3438 | 0.27 | Why? |
| Drug Synergism | 3 | 2021 | 833 | 0.27 | Why? |
| Endopeptidases | 1 | 2004 | 228 | 0.26 | Why? |
| Protein Conformation | 7 | 2021 | 4386 | 0.26 | Why? |
| Cell Survival | 3 | 2020 | 1581 | 0.26 | Why? |
| Respiratory Syncytial Viruses | 2 | 2018 | 612 | 0.26 | Why? |
| B-Lymphocytes | 1 | 2018 | 4418 | 0.26 | Why? |
| T-Lymphocytes | 4 | 2021 | 6670 | 0.26 | Why? |
| Steroids | 3 | 2008 | 904 | 0.25 | Why? |
| Cell Differentiation | 2 | 2020 | 1338 | 0.25 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2021 | 1267 | 0.25 | Why? |
| Swine | 3 | 2018 | 3352 | 0.25 | Why? |
| Kidney Transplantation | 3 | 2020 | 5397 | 0.24 | Why? |
| Child, Preschool | 16 | 2021 | 36283 | 0.24 | Why? |
| Bacterial Proteins | 3 | 2017 | 1318 | 0.24 | Why? |
| Cattle | 2 | 2019 | 1336 | 0.24 | Why? |
| Indoles | 2 | 2021 | 1243 | 0.24 | Why? |
| Klebsiella Infections | 2 | 2017 | 466 | 0.24 | Why? |
| Infant | 12 | 2021 | 30274 | 0.24 | Why? |
| Gastroenteritis | 1 | 2007 | 489 | 0.24 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.24 | Why? |
| Antibodies, Fungal | 2 | 2014 | 49 | 0.23 | Why? |
| Influenza Vaccines | 2 | 2018 | 2941 | 0.23 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2019 | 711 | 0.23 | Why? |
| Immunogenicity, Vaccine | 1 | 2017 | 4624 | 0.23 | Why? |
| Candidiasis | 2 | 2019 | 334 | 0.23 | Why? |
| Cysteine Endopeptidases | 3 | 2005 | 1557 | 0.23 | Why? |
| United States Food and Drug Administration | 2 | 2020 | 1276 | 0.23 | Why? |
| Databases, Genetic | 1 | 2007 | 1127 | 0.22 | Why? |
| Class III Phosphatidylinositol 3-Kinases | 1 | 2020 | 16 | 0.22 | Why? |
| Viral Plaque Assay | 3 | 2020 | 381 | 0.22 | Why? |
| Iodoquinol | 1 | 2020 | 16 | 0.22 | Why? |
| Administration, Oral | 4 | 2018 | 2340 | 0.22 | Why? |
| Blotting, Western | 6 | 2005 | 863 | 0.22 | Why? |
| Ranitidine | 1 | 2020 | 27 | 0.22 | Why? |
| Hospitals, Teaching | 3 | 2019 | 1609 | 0.22 | Why? |
| Seroepidemiologic Studies | 6 | 2019 | 10017 | 0.22 | Why? |
| Immunodominant Epitopes | 3 | 2021 | 813 | 0.22 | Why? |
| Fluorescent Antibody Technique, Indirect | 3 | 2013 | 393 | 0.21 | Why? |
| Life Cycle Stages | 1 | 2021 | 162 | 0.21 | Why? |
| RNA Helicases | 2 | 2020 | 413 | 0.21 | Why? |
| Binding Sites | 6 | 2021 | 6201 | 0.21 | Why? |
| Bismuth | 1 | 2020 | 56 | 0.21 | Why? |
| Genomics | 4 | 2021 | 3118 | 0.21 | Why? |
| Androstenes | 1 | 2020 | 65 | 0.21 | Why? |
| Nervous System Diseases | 2 | 2020 | 4092 | 0.21 | Why? |
| Hospitalization | 10 | 2021 | 54280 | 0.21 | Why? |
| Guinea Pigs | 2 | 2014 | 420 | 0.21 | Why? |
| Young Adult | 17 | 2021 | 93724 | 0.21 | Why? |
| Phosphorylation | 3 | 2020 | 1060 | 0.21 | Why? |
| Interferon-gamma | 3 | 2018 | 2711 | 0.21 | Why? |
| DNA Primers | 3 | 2019 | 1170 | 0.21 | Why? |
| Mucormycosis | 1 | 2010 | 832 | 0.21 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.21 | Why? |
| Proteasome Inhibitors | 1 | 2021 | 127 | 0.21 | Why? |
| Polymerase Chain Reaction | 7 | 2020 | 6740 | 0.20 | Why? |
| Benzoxazines | 1 | 2020 | 103 | 0.20 | Why? |
| Anti-Bacterial Agents | 4 | 2021 | 10083 | 0.20 | Why? |
| Sequence Deletion | 3 | 2020 | 674 | 0.20 | Why? |
| DNA Helicases | 1 | 2021 | 203 | 0.20 | Why? |
| Glycerophospholipids | 1 | 2019 | 12 | 0.20 | Why? |
| Turbinates | 1 | 2021 | 205 | 0.20 | Why? |
| Adolescent | 19 | 2021 | 86841 | 0.20 | Why? |
| Drug Therapy, Combination | 5 | 2021 | 7268 | 0.20 | Why? |
| Biological Availability | 1 | 2021 | 388 | 0.20 | Why? |
| Staphylococcal Scalded Skin Syndrome | 1 | 2018 | 2 | 0.20 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.20 | Why? |
| Reagent Kits, Diagnostic | 3 | 2018 | 2149 | 0.20 | Why? |
| HIV Infections | 3 | 2020 | 11620 | 0.20 | Why? |
| Candida tropicalis | 1 | 2019 | 21 | 0.20 | Why? |
| Drug Approval | 2 | 2020 | 1325 | 0.20 | Why? |
| Ketones | 1 | 2021 | 150 | 0.20 | Why? |
| Cell Fusion | 1 | 2021 | 400 | 0.19 | Why? |
| Neural Stem Cells | 1 | 2020 | 135 | 0.19 | Why? |
| Time Factors | 12 | 2020 | 31397 | 0.19 | Why? |
| Tretinoin | 1 | 2020 | 99 | 0.19 | Why? |
| DNA, Protozoan | 1 | 2019 | 77 | 0.19 | Why? |
| Sea Lions | 1 | 2018 | 2 | 0.19 | Why? |
| Immunoassay | 4 | 2021 | 4485 | 0.19 | Why? |
| Retinoids | 1 | 2019 | 43 | 0.19 | Why? |
| Biosynthetic Pathways | 1 | 2019 | 97 | 0.19 | Why? |
| Type III Secretion Systems | 1 | 2018 | 10 | 0.19 | Why? |
| Linoleic Acid | 1 | 2019 | 65 | 0.19 | Why? |
| Sequence Analysis, Protein | 1 | 2020 | 309 | 0.19 | Why? |
| Practice Guidelines as Topic | 5 | 2021 | 15421 | 0.19 | Why? |
| Models, Molecular | 7 | 2021 | 7616 | 0.19 | Why? |
| Tumor Cells, Cultured | 2 | 2017 | 254 | 0.19 | Why? |
| Immunoglobulin G | 12 | 2020 | 21571 | 0.19 | Why? |
| Heparitin Sulfate | 1 | 2021 | 285 | 0.19 | Why? |
| Defective Viruses | 1 | 2019 | 98 | 0.19 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.19 | Why? |
| Transforming Growth Factor beta1 | 1 | 2020 | 204 | 0.19 | Why? |
| Gene Deletion | 1 | 2020 | 430 | 0.19 | Why? |
| Vaccines, Inactivated | 2 | 2021 | 1562 | 0.19 | Why? |
| Adenine | 1 | 2021 | 463 | 0.18 | Why? |
| Novobiocin | 1 | 2017 | 8 | 0.18 | Why? |
| Firefly Luciferin | 1 | 2017 | 1 | 0.18 | Why? |
| Interferon-alpha | 3 | 2017 | 1442 | 0.18 | Why? |
| Immunoglobulin M | 6 | 2021 | 9091 | 0.18 | Why? |
| Naphthols | 1 | 2017 | 8 | 0.18 | Why? |
| Olfactory Mucosa | 1 | 2021 | 372 | 0.18 | Why? |
| Electron Transport Complex IV | 1 | 2017 | 21 | 0.18 | Why? |
| Acinetobacter | 1 | 2018 | 58 | 0.18 | Why? |
| Salmonella typhimurium | 1 | 2018 | 81 | 0.18 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.18 | Why? |
| Ligases | 1 | 2017 | 36 | 0.18 | Why? |
| Laundry Service, Hospital | 1 | 2017 | 10 | 0.18 | Why? |
| Clindamycin | 1 | 2018 | 59 | 0.18 | Why? |
| Receptors, Immunologic | 2 | 2020 | 555 | 0.17 | Why? |
| Fluorescent Antibody Technique, Direct | 1 | 2017 | 69 | 0.17 | Why? |
| Brain Diseases | 1 | 2010 | 1463 | 0.17 | Why? |
| Carbapenems | 2 | 2018 | 343 | 0.17 | Why? |
| Enterocytes | 1 | 2020 | 245 | 0.17 | Why? |
| Transduction, Genetic | 1 | 2018 | 273 | 0.17 | Why? |
| Molecular Docking Simulation | 5 | 2021 | 6902 | 0.17 | Why? |
| Databases, Pharmaceutical | 1 | 2020 | 345 | 0.17 | Why? |
| Dependovirus | 3 | 2008 | 272 | 0.17 | Why? |
| Intestine, Small | 2 | 2017 | 336 | 0.17 | Why? |
| Staphylococcal Skin Infections | 1 | 2017 | 32 | 0.17 | Why? |
| Integrins | 1 | 2019 | 158 | 0.17 | Why? |
| Biological Assay | 1 | 2020 | 367 | 0.17 | Why? |
| Ubiquitination | 1 | 2019 | 343 | 0.17 | Why? |
| Plasmids | 3 | 2018 | 840 | 0.17 | Why? |
| Boidae | 1 | 2017 | 25 | 0.17 | Why? |
| Base Composition | 2 | 2015 | 203 | 0.17 | Why? |
| Injections, Intradermal | 1 | 2017 | 102 | 0.17 | Why? |
| HIV-1 | 4 | 2020 | 3365 | 0.17 | Why? |
| Health Personnel | 7 | 2020 | 29646 | 0.17 | Why? |
| Survival Analysis | 4 | 2018 | 7592 | 0.17 | Why? |
| RAW 264.7 Cells | 1 | 2018 | 316 | 0.17 | Why? |
| Child | 17 | 2021 | 70012 | 0.17 | Why? |
| Gene Order | 1 | 2017 | 144 | 0.17 | Why? |
| Herpesvirus 3, Human | 1 | 2019 | 228 | 0.17 | Why? |
| Penicillium | 2 | 2011 | 14 | 0.16 | Why? |
| Phosphotransferases | 1 | 2016 | 16 | 0.16 | Why? |
| Chaperonin 60 | 1 | 2016 | 42 | 0.16 | Why? |
| Adaptive Immunity | 2 | 2020 | 2585 | 0.16 | Why? |
| Alanine | 4 | 2021 | 5687 | 0.16 | Why? |
| Hydrogen-Ion Concentration | 1 | 2020 | 993 | 0.16 | Why? |
| Communicable Disease Control | 3 | 2020 | 29620 | 0.16 | Why? |
| RNA Splicing | 1 | 2017 | 119 | 0.16 | Why? |
| Antigens | 1 | 2018 | 267 | 0.16 | Why? |
| Enterovirus D, Human | 1 | 2017 | 96 | 0.16 | Why? |
| Abscess | 1 | 2019 | 234 | 0.16 | Why? |
| Escherichia coli Proteins | 2 | 2009 | 168 | 0.16 | Why? |
| Reassortant Viruses | 1 | 2018 | 287 | 0.16 | Why? |
| Endoribonucleases | 1 | 2020 | 407 | 0.16 | Why? |
| Exoribonucleases | 1 | 2020 | 455 | 0.15 | Why? |
| Microarray Analysis | 2 | 2009 | 262 | 0.15 | Why? |
| Hematologic Tests | 1 | 2020 | 521 | 0.15 | Why? |
| Interferon Type I | 4 | 2019 | 2789 | 0.15 | Why? |
| Enzyme Assays | 1 | 2017 | 295 | 0.15 | Why? |
| Microscopy, Fluorescence | 3 | 2017 | 335 | 0.15 | Why? |
| Medical Records | 1 | 2018 | 513 | 0.15 | Why? |
| Immunity, Mucosal | 2 | 2017 | 426 | 0.15 | Why? |
| Interferon Regulatory Factor-3 | 2 | 2016 | 379 | 0.15 | Why? |
| Sewage | 1 | 2021 | 591 | 0.15 | Why? |
| Serine Proteases | 1 | 2017 | 211 | 0.15 | Why? |
| Chromatography, Liquid | 1 | 2019 | 640 | 0.15 | Why? |
| Codon | 2 | 2007 | 287 | 0.15 | Why? |
| GPI-Linked Proteins | 1 | 2016 | 317 | 0.15 | Why? |
| Adenosine Monophosphate | 3 | 2021 | 5652 | 0.15 | Why? |
| Viral Structural Proteins | 1 | 2019 | 491 | 0.14 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.14 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.14 | Why? |
| Mice, Knockout | 1 | 2020 | 1815 | 0.14 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
| Survival Rate | 3 | 2020 | 9206 | 0.14 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.14 | Why? |
| Epitopes | 4 | 2021 | 4113 | 0.14 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.14 | Why? |
| Methyltransferases | 1 | 2020 | 720 | 0.14 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.14 | Why? |
| Fluorescence | 1 | 2017 | 475 | 0.14 | Why? |
| Gastrointestinal Diseases | 1 | 2010 | 2580 | 0.14 | Why? |
| B7-2 Antigen | 1 | 2014 | 56 | 0.14 | Why? |
| Palatine Tonsil | 1 | 2015 | 127 | 0.14 | Why? |
| Heart Valves | 1 | 2014 | 52 | 0.14 | Why? |
| Family Health | 1 | 2020 | 731 | 0.14 | Why? |
| Pyrimidinones | 2 | 2004 | 76 | 0.14 | Why? |
| Neisseriaceae | 1 | 2013 | 1 | 0.13 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.13 | Why? |
| RNA-Binding Proteins | 2 | 2014 | 1022 | 0.13 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.13 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.13 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.13 | Why? |
| Genetic Vectors | 3 | 2018 | 1600 | 0.13 | Why? |
| Phaeohyphomycosis | 1 | 2012 | 7 | 0.13 | Why? |
| Exophiala | 1 | 2012 | 6 | 0.13 | Why? |
| Rectum | 1 | 2017 | 495 | 0.13 | Why? |
| DEAD-box RNA Helicases | 1 | 2014 | 99 | 0.13 | Why? |
| Costs and Cost Analysis | 1 | 2018 | 694 | 0.13 | Why? |
| Furin | 1 | 2021 | 1054 | 0.13 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.13 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 526 | 0.13 | Why? |
| Prevalence | 5 | 2020 | 25773 | 0.13 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.13 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 572 | 0.13 | Why? |
| Autophagy | 1 | 2020 | 960 | 0.13 | Why? |
| Computational Biology | 2 | 2007 | 4514 | 0.13 | Why? |
| Cats | 2 | 2012 | 1890 | 0.12 | Why? |
| Laboratories, Hospital | 1 | 2017 | 489 | 0.12 | Why? |
| Pyrimidines | 2 | 2020 | 1557 | 0.12 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.12 | Why? |
| Treatment Outcome | 9 | 2019 | 51732 | 0.12 | Why? |
| Intensive Care Units, Neonatal | 1 | 2019 | 749 | 0.12 | Why? |
| Small Molecule Libraries | 2 | 2020 | 1060 | 0.12 | Why? |
| Tandem Mass Spectrometry | 1 | 2019 | 1031 | 0.12 | Why? |
| Molecular Structure | 3 | 2021 | 1539 | 0.12 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.12 | Why? |
| Vaccination | 6 | 2021 | 19050 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Infant, Newborn | 6 | 2020 | 23105 | 0.12 | Why? |
| Pichia | 1 | 2011 | 42 | 0.12 | Why? |
| Liver | 2 | 2017 | 4007 | 0.12 | Why? |
| Air Pollution, Indoor | 1 | 2021 | 816 | 0.12 | Why? |
| Gastrointestinal Tract | 1 | 2020 | 1113 | 0.12 | Why? |
| Mice, Inbred C57BL | 2 | 2020 | 5542 | 0.12 | Why? |
| Protein Processing, Post-Translational | 3 | 2019 | 634 | 0.12 | Why? |
| TNF Receptor-Associated Factor 3 | 3 | 2019 | 43 | 0.12 | Why? |
| Human bocavirus | 1 | 2012 | 142 | 0.12 | Why? |
| Ships | 1 | 2020 | 1046 | 0.12 | Why? |
| Brain | 2 | 2020 | 5133 | 0.11 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.11 | Why? |
| Conserved Sequence | 3 | 2019 | 751 | 0.11 | Why? |
| Methylprednisolone | 2 | 2021 | 2107 | 0.11 | Why? |
| Travel | 2 | 2021 | 7220 | 0.11 | Why? |
| Saudi Arabia | 4 | 2018 | 4423 | 0.11 | Why? |
| Diarrhea | 1 | 2004 | 2743 | 0.11 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.11 | Why? |
| Campylobacter fetus | 1 | 1990 | 3 | 0.11 | Why? |
| Milk, Human | 1 | 2020 | 956 | 0.11 | Why? |
| Signal Transduction | 5 | 2020 | 7207 | 0.11 | Why? |
| Disease Vectors | 1 | 2013 | 208 | 0.11 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.11 | Why? |
| Viverridae | 2 | 2015 | 225 | 0.11 | Why? |
| Mycophenolic Acid | 1 | 2013 | 383 | 0.11 | Why? |
| Adaptation, Biological | 1 | 2012 | 179 | 0.11 | Why? |
| CD4-Positive T-Lymphocytes | 4 | 2020 | 4545 | 0.11 | Why? |
| Sheep | 1 | 2012 | 420 | 0.11 | Why? |
| Immunization, Passive | 4 | 2021 | 10067 | 0.11 | Why? |
| Virus Cultivation | 2 | 2013 | 579 | 0.11 | Why? |
| Histocompatibility Antigens Class II | 1 | 2014 | 383 | 0.11 | Why? |
| Biomarkers | 6 | 2020 | 23361 | 0.11 | Why? |
| Bronchi | 2 | 2019 | 1048 | 0.11 | Why? |
| Molecular Sequence Annotation | 1 | 2013 | 478 | 0.11 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.11 | Why? |
| Genes, Fungal | 1 | 2010 | 21 | 0.11 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.11 | Why? |
| Campylobacter Infections | 1 | 1990 | 37 | 0.11 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.11 | Why? |
| Seizures, Febrile | 2 | 2012 | 59 | 0.11 | Why? |
| Protein Interaction Maps | 1 | 2018 | 1333 | 0.10 | Why? |
| Dermatitis, Atopic | 1 | 2018 | 714 | 0.10 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2019 | 904 | 0.10 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.10 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2011 | 239 | 0.10 | Why? |
| Anti-Retroviral Agents | 1 | 2019 | 1099 | 0.10 | Why? |
| Databases, Nucleic Acid | 2 | 2011 | 272 | 0.10 | Why? |
| Antigen Presentation | 1 | 2013 | 524 | 0.10 | Why? |
| Peritonitis | 1 | 1992 | 217 | 0.10 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Glycosylation | 3 | 2011 | 1255 | 0.10 | Why? |
| RNA, Messenger | 3 | 2017 | 5131 | 0.10 | Why? |
| Vaccinia virus | 2 | 2019 | 346 | 0.10 | Why? |
| Viral Fusion Proteins | 1 | 2014 | 399 | 0.10 | Why? |
| Phosphoproteins | 4 | 2020 | 4346 | 0.10 | Why? |
| Demography | 1 | 2017 | 1660 | 0.10 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.10 | Why? |
| Fluorescein-5-isothiocyanate | 1 | 2008 | 15 | 0.10 | Why? |
| T-Lymphocyte Subsets | 1 | 2017 | 1387 | 0.10 | Why? |
| Synteny | 1 | 2008 | 38 | 0.10 | Why? |
| Drug Therapy | 1 | 2012 | 280 | 0.10 | Why? |
| Amides | 1 | 2021 | 1864 | 0.10 | Why? |
| Taiwan | 1 | 2018 | 2556 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.10 | Why? |
| Fibroblasts | 1 | 2013 | 839 | 0.10 | Why? |
| Plasma | 1 | 2019 | 1809 | 0.09 | Why? |
| Peptide Hydrolases | 1 | 2017 | 1269 | 0.09 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.09 | Why? |
| Antifungal Agents | 2 | 2019 | 1828 | 0.09 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.09 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Healthy Volunteers | 1 | 2014 | 1444 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Nucleic Acid Amplification Techniques | 4 | 2019 | 3388 | 0.09 | Why? |
| Carboxypeptidases | 2 | 2005 | 148 | 0.09 | Why? |
| Genome | 1 | 2010 | 341 | 0.09 | Why? |
| Gene Silencing | 1 | 2008 | 213 | 0.09 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Homes for the Aged | 1 | 2018 | 1071 | 0.09 | Why? |
| Kidney Diseases | 1 | 2019 | 1434 | 0.08 | Why? |
| Retrospective Studies | 8 | 2020 | 105322 | 0.08 | Why? |
| Immune Sera | 1 | 2012 | 884 | 0.08 | Why? |
| Swine Diseases | 1 | 2017 | 1219 | 0.08 | Why? |
| Immunologic Factors | 2 | 2019 | 4206 | 0.08 | Why? |
| False Positive Reactions | 2 | 2020 | 1338 | 0.08 | Why? |
| Cytosine | 1 | 2007 | 92 | 0.08 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.08 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.08 | Why? |
| Administration, Intranasal | 2 | 2008 | 1132 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Tandem Repeat Sequences | 1 | 2006 | 78 | 0.08 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.08 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.08 | Why? |
| Factor Xa | 1 | 2007 | 113 | 0.08 | Why? |
| Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.08 | Why? |
| Japan | 1 | 2020 | 6653 | 0.08 | Why? |
| Cost-Benefit Analysis | 1 | 2016 | 2259 | 0.08 | Why? |
| Risk Factors | 7 | 2019 | 71621 | 0.08 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.08 | Why? |
| Peritoneal Dialysis | 1 | 1992 | 498 | 0.08 | Why? |
| CpG Islands | 1 | 2007 | 230 | 0.08 | Why? |
| Protein Structure, Tertiary | 3 | 2006 | 1565 | 0.08 | Why? |
| Cysteine Proteinase Inhibitors | 2 | 2020 | 675 | 0.08 | Why? |
| Body Weight | 1 | 2012 | 1074 | 0.08 | Why? |
| Computer Simulation | 2 | 2021 | 4982 | 0.08 | Why? |
| Gene Expression | 3 | 2015 | 3332 | 0.08 | Why? |
| Genes | 1 | 2005 | 50 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2019 | 4002 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Mouth Mucosa | 1 | 2009 | 323 | 0.08 | Why? |
| Protein Domains | 4 | 2021 | 6563 | 0.07 | Why? |
| Statistics, Nonparametric | 1 | 2009 | 1008 | 0.07 | Why? |
| Transfection | 1 | 2008 | 864 | 0.07 | Why? |
| Rimantadine | 1 | 2004 | 13 | 0.07 | Why? |
| Chlorogenic Acid | 1 | 2004 | 25 | 0.07 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 9335 | 0.07 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Virus Activation | 2 | 2007 | 480 | 0.07 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.07 | Why? |
| Epitope Mapping | 3 | 2020 | 1240 | 0.07 | Why? |
| Combinatorial Chemistry Techniques | 1 | 2004 | 54 | 0.07 | Why? |
| Histidine | 1 | 2005 | 72 | 0.07 | Why? |
| Cystitis | 1 | 2005 | 45 | 0.07 | Why? |
| Radiography, Thoracic | 2 | 2020 | 5486 | 0.07 | Why? |
| Polymorphism, Genetic | 2 | 2010 | 1074 | 0.07 | Why? |
| Sequence Analysis, RNA | 3 | 2021 | 2290 | 0.07 | Why? |
| Poultry | 1 | 2006 | 437 | 0.07 | Why? |
| Glutamine | 1 | 2005 | 111 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.07 | Why? |
| Fluorescent Antibody Technique | 2 | 2005 | 835 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2021 | 3550 | 0.07 | Why? |
| Comorbidity | 4 | 2018 | 34796 | 0.07 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.07 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.07 | Why? |
| Histocytochemistry | 2 | 2014 | 88 | 0.07 | Why? |
| Fluorescent Dyes | 1 | 2008 | 536 | 0.07 | Why? |
| Pneumonia | 2 | 2004 | 5652 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2020 | 5837 | 0.07 | Why? |
| Aspergillus | 1 | 2007 | 347 | 0.07 | Why? |
| Case-Control Studies | 4 | 2019 | 17671 | 0.07 | Why? |
| Immunoglobulin A | 3 | 2008 | 3567 | 0.07 | Why? |
| Bacterial Vaccines | 1 | 2005 | 139 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Antibody Specificity | 2 | 2011 | 1328 | 0.07 | Why? |
| High-Throughput Screening Assays | 1 | 2013 | 1783 | 0.07 | Why? |
| Kinetics | 3 | 2014 | 3238 | 0.07 | Why? |
| Spectrometry, Fluorescence | 1 | 2004 | 177 | 0.07 | Why? |
| Aspergillosis | 1 | 2007 | 264 | 0.07 | Why? |
| Interleukin-4 | 1 | 2005 | 367 | 0.07 | Why? |
| BK Virus | 1 | 2005 | 135 | 0.07 | Why? |
| Carnivora | 1 | 2003 | 47 | 0.07 | Why? |
| Acute Disease | 2 | 2007 | 6029 | 0.07 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.07 | Why? |
| Polyomavirus Infections | 1 | 2005 | 156 | 0.06 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.06 | Why? |
| Mycological Typing Techniques | 2 | 2012 | 38 | 0.06 | Why? |
| Structure-Activity Relationship | 2 | 2021 | 2219 | 0.06 | Why? |
| Nucleic Acid Conformation | 1 | 2006 | 621 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
| Pregnancy | 4 | 2020 | 23879 | 0.06 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2006 | 9706 | 0.06 | Why? |
| Immunotherapy | 2 | 2017 | 2421 | 0.06 | Why? |
| Models, Animal | 1 | 2005 | 788 | 0.06 | Why? |
| Glycyrrhizic Acid | 1 | 2004 | 190 | 0.06 | Why? |
| Confidence Intervals | 1 | 2005 | 744 | 0.06 | Why? |
| Inhibitory Concentration 50 | 2 | 2016 | 907 | 0.06 | Why? |
| Immunization Schedule | 2 | 2008 | 1305 | 0.06 | Why? |
| Vaccines, Synthetic | 3 | 2018 | 3231 | 0.06 | Why? |
| United States | 2 | 2020 | 46150 | 0.06 | Why? |
| Point Mutation | 1 | 2005 | 481 | 0.06 | Why? |
| RNA | 1 | 2009 | 1278 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.06 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.06 | Why? |
| Calpain | 1 | 2021 | 39 | 0.06 | Why? |
| Interferon beta-1a | 1 | 2004 | 316 | 0.06 | Why? |
| Immunization, Secondary | 2 | 2008 | 1649 | 0.05 | Why? |
| Cloning, Molecular | 1 | 2004 | 1036 | 0.05 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2021 | 138 | 0.05 | Why? |
| World Health Organization | 2 | 2012 | 4213 | 0.05 | Why? |
| Autophagy-Related Protein-1 Homolog | 1 | 2020 | 32 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.05 | Why? |
| Prognosis | 4 | 2017 | 32490 | 0.05 | Why? |
| Lipogenesis | 1 | 2020 | 49 | 0.05 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2004 | 669 | 0.05 | Why? |
| Probability | 1 | 2005 | 923 | 0.05 | Why? |
| Immunity, Cellular | 2 | 2018 | 3614 | 0.05 | Why? |
| HIV Protease Inhibitors | 1 | 2004 | 434 | 0.05 | Why? |
| Reference Standards | 2 | 2020 | 1163 | 0.05 | Why? |
| Microscopy | 2 | 2014 | 414 | 0.05 | Why? |
| SUMO-1 Protein | 1 | 2019 | 13 | 0.05 | Why? |
| Sumoylation | 1 | 2019 | 21 | 0.05 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.05 | Why? |
| Autophagy-Related Proteins | 1 | 2020 | 157 | 0.05 | Why? |
| Asymptomatic Diseases | 1 | 2012 | 3444 | 0.05 | Why? |
| Flavonoids | 1 | 2004 | 492 | 0.05 | Why? |
| Peptide Fragments | 2 | 2016 | 2075 | 0.05 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2021 | 249 | 0.05 | Why? |
| Sequence Homology, Nucleic Acid | 2 | 2015 | 368 | 0.05 | Why? |
| Hydrazones | 1 | 2020 | 216 | 0.05 | Why? |
| Transportation | 1 | 2005 | 691 | 0.05 | Why? |
| Proline | 1 | 2021 | 345 | 0.05 | Why? |
| Animal Structures | 1 | 2018 | 61 | 0.05 | Why? |
| Mice, SCID | 1 | 2019 | 225 | 0.05 | Why? |
| Microspheres | 1 | 2020 | 261 | 0.05 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Arginine | 1 | 2021 | 377 | 0.05 | Why? |
| Pregnancy, Animal | 1 | 2017 | 15 | 0.05 | Why? |
| Morpholines | 1 | 2020 | 351 | 0.05 | Why? |
| DNA, Helminth | 1 | 2017 | 15 | 0.04 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 334 | 0.04 | Why? |
| Receptors, CCR | 1 | 2017 | 26 | 0.04 | Why? |
| Crystallography, X-Ray | 3 | 2014 | 2689 | 0.04 | Why? |
| Triazines | 1 | 2020 | 246 | 0.04 | Why? |
| Nuclear Localization Signals | 1 | 2017 | 85 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Bacterial Typing Techniques | 1 | 2019 | 273 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Antiretroviral Therapy, Highly Active | 2 | 2019 | 952 | 0.04 | Why? |
| Amino Acid Substitution | 1 | 2005 | 1706 | 0.04 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 533 | 0.04 | Why? |
| Enhancer Elements, Genetic | 1 | 2017 | 48 | 0.04 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.04 | Why? |
| Blood | 1 | 2018 | 274 | 0.04 | Why? |
| Mice, Inbred ICR | 1 | 2017 | 242 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 3 | 2020 | 11559 | 0.04 | Why? |
| Influenza A Virus, H9N2 Subtype | 1 | 2017 | 61 | 0.04 | Why? |
| Escherichia coli | 1 | 2004 | 1547 | 0.04 | Why? |
| Exons | 1 | 2017 | 158 | 0.04 | Why? |
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 106 | 0.04 | Why? |
| STAT2 Transcription Factor | 1 | 2017 | 141 | 0.04 | Why? |
| beta-Defensins | 1 | 2016 | 38 | 0.04 | Why? |
| Dairying | 1 | 2015 | 46 | 0.04 | Why? |
| Sendai virus | 1 | 2016 | 111 | 0.04 | Why? |
| Host Specificity | 1 | 2020 | 926 | 0.04 | Why? |
| Animals, Wild | 1 | 2003 | 1028 | 0.04 | Why? |
| Primates | 1 | 2018 | 584 | 0.04 | Why? |
| Flavivirus | 1 | 2017 | 182 | 0.04 | Why? |
| Models, Biological | 2 | 2020 | 4907 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.04 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2020 | 584 | 0.04 | Why? |
| Epidemiologic Studies | 1 | 2017 | 554 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2020 | 3776 | 0.04 | Why? |
| Microscopy, Confocal | 2 | 2007 | 343 | 0.04 | Why? |
| Macrophages, Alveolar | 1 | 2019 | 668 | 0.04 | Why? |
| Flow Cytometry | 2 | 2017 | 2393 | 0.03 | Why? |
| Patient Isolation | 1 | 2008 | 3182 | 0.03 | Why? |
| Immune Evasion | 2 | 2016 | 2081 | 0.03 | Why? |
| Transposases | 1 | 2013 | 30 | 0.03 | Why? |
| Beijing | 1 | 2017 | 912 | 0.03 | Why? |
| HeLa Cells | 2 | 2009 | 1303 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.03 | Why? |
| Ultrasonography, Interventional | 1 | 2019 | 560 | 0.03 | Why? |
| Ventilation | 1 | 2021 | 1145 | 0.03 | Why? |
| Urine | 2 | 2007 | 469 | 0.03 | Why? |
| Forecasting | 1 | 2008 | 4492 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| RNA Polymerase II | 1 | 2012 | 29 | 0.03 | Why? |
| DNA, Ribosomal Spacer | 1 | 2012 | 49 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2021 | 1357 | 0.03 | Why? |
| Adenosine | 1 | 2017 | 509 | 0.03 | Why? |
| Disease Progression | 5 | 2020 | 13580 | 0.03 | Why? |
| Tubulin | 1 | 2012 | 67 | 0.03 | Why? |
| Mutagenesis, Site-Directed | 1 | 2014 | 449 | 0.03 | Why? |
| DNA, Fungal | 1 | 2012 | 95 | 0.03 | Why? |
| Predictive Value of Tests | 1 | 2008 | 9537 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.03 | Why? |
| Actins | 1 | 2012 | 108 | 0.03 | Why? |
| Endoplasmic Reticulum | 2 | 2006 | 430 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2020 | 2372 | 0.03 | Why? |
| Patients | 1 | 2020 | 1167 | 0.03 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.03 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.03 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2020 | 1445 | 0.03 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2014 | 245 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Proportional Hazards Models | 1 | 2004 | 6543 | 0.03 | Why? |
| Bone Marrow Transplantation | 1 | 1995 | 343 | 0.03 | Why? |
| Protein Interaction Mapping | 1 | 2014 | 487 | 0.03 | Why? |
| Workflow | 1 | 2021 | 2373 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2019 | 2134 | 0.03 | Why? |
| Global Health | 2 | 2005 | 13911 | 0.03 | Why? |
| Phylogeography | 1 | 2015 | 824 | 0.03 | Why? |
| California | 1 | 2018 | 2047 | 0.03 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 2426 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.03 | Why? |
| Peptide Library | 1 | 2014 | 564 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Blood Donors | 1 | 2004 | 2956 | 0.03 | Why? |
| Drug Design | 2 | 2017 | 2627 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Water Microbiology | 1 | 1992 | 248 | 0.03 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.03 | Why? |
| Genome, Bacterial | 1 | 2013 | 446 | 0.02 | Why? |
| Internet | 1 | 2007 | 6204 | 0.02 | Why? |
| Fever | 2 | 2020 | 7795 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| I-kappa B Kinase | 1 | 2009 | 98 | 0.02 | Why? |
| Antibody Affinity | 1 | 2014 | 1078 | 0.02 | Why? |
| BALB 3T3 Cells | 1 | 2008 | 9 | 0.02 | Why? |
| Virion | 1 | 2017 | 1444 | 0.02 | Why? |
| Spores, Fungal | 1 | 2007 | 23 | 0.02 | Why? |
| Hyphae | 1 | 2007 | 22 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Crystallization | 1 | 2009 | 331 | 0.02 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| CCAAT-Enhancer-Binding Proteins | 1 | 2006 | 17 | 0.02 | Why? |
| Galactose | 1 | 2007 | 201 | 0.02 | Why? |
| Protein Denaturation | 1 | 2006 | 78 | 0.02 | Why? |
| Mannans | 1 | 2007 | 218 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2017 | 1881 | 0.02 | Why? |
| Serum | 1 | 2007 | 294 | 0.02 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2006 | 113 | 0.02 | Why? |
| Coronavirus NL63, Human | 1 | 2012 | 669 | 0.02 | Why? |
| Pyrrolidinones | 1 | 2005 | 66 | 0.02 | Why? |
| Filtration | 1 | 2011 | 820 | 0.02 | Why? |
| Molecular Chaperones | 1 | 2006 | 124 | 0.02 | Why? |
| Chemokines, CXC | 1 | 2005 | 68 | 0.02 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 238 | 0.02 | Why? |
| Oxazoles | 1 | 2005 | 75 | 0.02 | Why? |
| Cytoplasmic Vesicles | 1 | 2005 | 74 | 0.02 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 502 | 0.02 | Why? |
| Mannose | 1 | 2005 | 68 | 0.02 | Why? |
| RNA, Ribosomal, 18S | 1 | 2004 | 68 | 0.02 | Why? |
| Golgi Apparatus | 1 | 2005 | 178 | 0.02 | Why? |
| Antigens, Surface | 1 | 2005 | 181 | 0.02 | Why? |
| Ofloxacin | 1 | 2003 | 23 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 343 | 0.02 | Why? |
| Transplantation, Autologous | 1 | 2005 | 364 | 0.02 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2003 | 72 | 0.02 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2008 | 552 | 0.02 | Why? |
| DNA Probes | 1 | 2004 | 178 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2018 | 4849 | 0.02 | Why? |
| Pulse Therapy, Drug | 1 | 2003 | 137 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Age Factors | 1 | 2004 | 21039 | 0.02 | Why? |
| Adenoviridae | 1 | 2009 | 1151 | 0.02 | Why? |
| Chemokine CCL2 | 1 | 2005 | 389 | 0.02 | Why? |
| Autopsy | 1 | 2014 | 3495 | 0.02 | Why? |
| 3' Untranslated Regions | 1 | 2003 | 318 | 0.01 | Why? |
| Oligopeptides | 1 | 2005 | 576 | 0.01 | Why? |
| DNA, Complementary | 1 | 2003 | 568 | 0.01 | Why? |
| Transmissible gastroenteritis virus | 1 | 2005 | 614 | 0.01 | Why? |
| Chemokine CXCL10 | 1 | 2005 | 565 | 0.01 | Why? |
| Lung Diseases | 1 | 1995 | 2361 | 0.01 | Why? |
| Microscopy, Electron | 1 | 2003 | 830 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Epidemiological Monitoring | 1 | 2012 | 3493 | 0.01 | Why? |
| Virology | 1 | 2003 | 489 | 0.01 | Why? |
| Infusions, Intravenous | 1 | 2003 | 1224 | 0.01 | Why? |
| Vietnam | 1 | 2004 | 1665 | 0.01 | Why? |
| Nasal Cavity | 1 | 2004 | 909 | 0.01 | Why? |
| Polysaccharides | 1 | 2005 | 854 | 0.01 | Why? |
| False Negative Reactions | 1 | 2004 | 1785 | 0.01 | Why? |
| Nose | 1 | 2003 | 1093 | 0.01 | Why? |
| Opportunistic Infections | 1 | 2003 | 602 | 0.01 | Why? |
| Pharynx | 1 | 2004 | 1544 | 0.01 | Why? |
| Membrane Proteins | 1 | 2006 | 1733 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Radiography | 1 | 2003 | 1576 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Singapore | 1 | 2004 | 3641 | 0.01 | Why? |
| Gene Expression Profiling | 1 | 2005 | 3788 | 0.01 | Why? |
| Lung Diseases, Fungal | 1 | 1995 | 167 | 0.01 | Why? |
| Anti-Infective Agents | 1 | 2004 | 1766 | 0.01 | Why? |
| Odds Ratio | 1 | 2004 | 5861 | 0.01 | Why? |
| Anti-HIV Agents | 1 | 2004 | 2209 | 0.01 | Why? |
| Canada | 1 | 2004 | 6018 | 0.01 | Why? |
| Cytomegalovirus Infections | 1 | 1995 | 667 | 0.01 | Why? |
| Glucocorticoids | 1 | 2004 | 4431 | 0.01 | Why? |
| Length of Stay | 1 | 2003 | 11042 | 0.00 | Why? |
| Tuberculosis, Pulmonary | 1 | 1995 | 1171 | 0.00 | Why? |
| Critical Care | 1 | 2004 | 14081 | 0.00 | Why? |
| Respiration, Artificial | 1 | 2004 | 22116 | 0.00 | Why? |